I think virus inactivation is a normal vaccination approach and is probably being pursued here? The hardest part is probably growing it in vitro at scale and perhaps ensuring that all of them are inactive.
You don’t need to grow it at scale and out of the two vaccine we have in trials one is adenovirus-based while the other is mRNA-based.
Current theme: default
Less Wrong (text)
Less Wrong (link)
Arrow keys: Next/previous image
Escape or click: Hide zoomed image
Space bar: Reset image size & position
Scroll to zoom in/out
(When zoomed in, drag to pan; double-click to close)
Keys shown in yellow (e.g., ]) are accesskeys, and require a browser-specific modifier key (or keys).
]
Keys shown in grey (e.g., ?) do not require any modifier keys.
?
Esc
h
f
a
m
v
c
r
q
t
u
o
,
.
/
s
n
e
;
Enter
[
\
k
i
l
=
-
0
′
1
2
3
4
5
6
7
8
9
→
↓
←
↑
Space
x
z
`
g
I think virus inactivation is a normal vaccination approach and is probably being pursued here? The hardest part is probably growing it in vitro at scale and perhaps ensuring that all of them are inactive.
You don’t need to grow it at scale and out of the two vaccine we have in trials one is adenovirus-based while the other is mRNA-based.